Ectopic Pregnancy Clinical Trial
Verified date | March 2019 |
Source | Ege University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Patients who have doubt for ectopic pregnancy will be enrolled for our study. These patients will be determined with using irregular increased human chorionic gonadotropin (beta-HCG) results and no embryo reported ultrasonography results. Plasma and cervical fluid samples will be taken from these patients and axonemal dynein heavy chain 5 and creatine kinase levels of samples will be compared between patients who have doubt for ectopic pregnancy and patients who have intrauterine pregnancy. Concentration of these proteins in samples will be evaluated. If any difference will be found between groups in favour of ectopic pregnancy, these results might be interpreted as these proteins useful for early detecting of the ectopic pregnancy.
Status | Completed |
Enrollment | 85 |
Est. completion date | November 2018 |
Est. primary completion date | June 2018 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years to 45 Years |
Eligibility |
Inclusion Criteria: - Doubted ectopic pregnancy - Without any finding about intrauterine pregnancy in ultrasonography results - Without any vaginal bleeding - Having irregular pregnancy test results - Beta-HCG results should be at least upper than 100 milli-International unit (mIU/ml) - Having fist trimester pregnancy for intrauterine pregnancy group - Without any emergency findings Exclusion Criteria: - Doubted incomplete abortion - Having vaginal bleeding - Having ultrasound results which include intrauterine embryo report - Having lower than 100 mIU/ml beta-HCG results - Without fetal heart rate in intrauterine pregnancy group - Having older than fist trimester pregnancy for intrauterine pregnancy group - Having emergency findings |
Country | Name | City | State |
---|---|---|---|
Turkey | Ege University, Medicine Faculty, Department of Obstetrics and Gynecology | Izmir |
Lead Sponsor | Collaborator |
---|---|
Ege University |
Turkey,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Concentration of Axonemal Dynein Heavy Chain 5 | 1 year | ||
Primary | Concentration of creatine kinase | 1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01876004 -
Effectiveness Of Expectant Management In The Tubal Ectopic Pregnancy
|
Phase 4 | |
Not yet recruiting |
NCT05039853 -
Improving Mental Health Following Early PREgnancy Loss Using a Brief Cognitive Task
|
N/A | |
Completed |
NCT00194207 -
Risk Factors of Ectopic Pregnancy
|
N/A | |
Completed |
NCT00827970 -
Randomized Population-Based Study on Chlamydia Trachomatis Screening
|
N/A | |
Recruiting |
NCT05374720 -
Analysis of the Molecular Composition of Tubal Cilia in Patients With or Without Ectopic Pregnancy
|
N/A | |
Completed |
NCT03894735 -
Vitamin D in Ectopic Pregnancies
|
||
Recruiting |
NCT01860690 -
BHCG Level in Day 4,7, in Comparison to Day 10 as an Indicator for Treatment Success
|
Phase 4 | |
Recruiting |
NCT04176549 -
Assessment of Biomarkers in Ectopic Pregnancy
|
||
Not yet recruiting |
NCT05890066 -
Single-port Versus Multi-port Laparoscopic Surgery for Ectopic Pregnancy
|
N/A | |
Completed |
NCT01855568 -
Methotrexate Treatment for Ectopic Pregnancy
|
Phase 3 | |
Not yet recruiting |
NCT04308343 -
The Aromatase Inhibitor and Gnrh Antagonist Versus Methotrexate for Management of Undisturbed Ectopic Pregnancy
|
N/A | |
Recruiting |
NCT06354439 -
Use of Letrozole for Ectopic Pregnancy
|
Phase 4 | |
Not yet recruiting |
NCT06300333 -
Treatment of Ectopic Pregnancy by Low Dose of Methotrexate
|
||
Completed |
NCT00194272 -
Two-Dose Methotrexate for Ectopic Pregnancy
|
Phase 3 | |
Enrolling by invitation |
NCT03579550 -
Hysteroscopic Metroplasty in Unexplained Infertile Women With Dysmorphic Uterus
|
N/A | |
Completed |
NCT05446012 -
Relationship Between Ectopic Pregnancy and Thyroid Disorders
|
||
Completed |
NCT00194168 -
Ectopic Pregnancy Biomarkers
|
N/A | |
Completed |
NCT02152696 -
Optimal Treatment for Women With a Persisting Pregnancy of Unknown Location
|
Phase 3 | |
Not yet recruiting |
NCT04975984 -
Expectant Management of Ectopic Pregnancy
|
||
Completed |
NCT04371991 -
Kisspeptin Levels in Early Pregnancy
|